290 results
Healthcare Spending as Function of GDP EU #PublicHealth #HealthcareSpending #GDP #EU15 #BMJ
as Function of GDP ... HealthcareSpending #GDP ... #EU15 #BMJ
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
normally inactivates GLP ... -1 and GIP. ... combination therapy with GLP-I ... Pharmacology #Summary #DM2
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Sulfonylureas GLP ... endocrinology #dm2
Hyperglycemic Crisis - Algorithm for DKA/HHS

Diagnostic criteria for DKA:
 • pH < 7.3
 • Anion gap
7.3 • Anion gap ... 7.3 • Anion gap ... endocrinology #Diabetes #DM2
Mechanism of Action of Platelet Aggregation Inhibitors
- COX Inhibitors
- ADP Inhibitors
- GP IIb/IIIa Receptor Blockers

#Antiplatelet #Pharmacolgy
Inhibitors - ADP ... Inhibitors - GP
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
Diabetes #T2D #DM2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
INCRETIN AGENTS • GLP ... - Prevents GLP ... #pharmacology #DM2
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
mL/minute/1.73 rm2 ... mL/minute/1.73 m2 ... Pharmacology #Summary #DM2
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
DecisionAid #Orals #DM2
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
Glycemic #Diabetes #DM2